Corporate News 31-Jan-22
Alkem Laboratories enters into exclusive license agreement with Johns Hopkins University
Alkem Laboratories and Johns Hopkins University (JHU) have entered into an exclusive license agreement for the development and commercialization of JHU's novel target and technology that will help patients with colorectal cancer. This technology, a novel target, will serve as a bona fide biomarker and antagonist in human colorectal cancer based on angiogenesis and inflammation.
Previous News
Alkem Laboratories schedules board meeting
( Corporate News - 16-May-24 18:46 )
Alkem Laboratories to conduct board meeting
( Corporate News - 30-Oct-23 16:12 )
Alkem Labs tanks on buzz of tax evasion
( Hot Pursuit - 26-Feb-24 14:25 )
Board of Alkem Laboratories appoints director
( Corporate News - 14-Sep-22 13:54 )
Alkem Laboratories Ltd leads losers in 'A' group
( Hot Pursuit - 26-Feb-24 15:00 )
Alkem Laboratories consolidated net profit rises 30.84% in the December 2023 quarter
( Results - Announcements 09-Feb-24 14:30 )
Alkem Laboratories Ltd spurts 1.54%, up for five straight sessions
( Hot Pursuit - 11-Aug-21 13:00 )
Board of Alkem Laboratories recommends Final Dividend
( Corporate News - 20-May-23 10:27 )
Alkem Laboratories standalone net profit rises 82.13% in the September 2019 quarter
( Results - Announcements 11-Nov-19 16:51 )
Board of Alkem Laboratories recommends interim dividend
( Corporate News - 11-Feb-23 11:51 )
US FDA concludes inspection at Alkem Labs' Ankleshwar unit with zero Form 483 observations
( Hot Pursuit - 08-Apr-23 11:45 )
Other Stories
Board of Delhivery approves alteration in capital clause of MoA
05-Jul-24 19:32
J B Chemicals & Pharmaceuticals appoints director
05-Jul-24 19:30
Infosys announces resignation of senior management personnel
05-Jul-24 19:22
JLR Q1 FY25 retail sales up 9% on YoY basis
05-Jul-24 19:08
Bajaj Auto launches world's first CNG motorcycle 'Freedom'
05-Jul-24 18:59
Agenda for board meeting of Power Grid Corporation of India
05-Jul-24 18:46
Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
05-Jul-24 18:06
Vipul to hold board meeting
05-Jul-24 17:15
Markobenz Ventures to convene board meeting
05-Jul-24 17:15
Dhanashree Electronics to declare Quarterly Result
05-Jul-24 17:15
Back
Top
